.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 5,135,943

« Back to Dashboard

Summary for Patent: 5,135,943

Title: 1H-imidazole derivative compounds and pharmaceutical compositions containing the same
Abstract:The 1H-imidazole derivative compound of formula I: ##STR1## and its nontoxic addition salts, particularly the nitrate addition salt, are more effective as antimycotic agents and are unexpectedly safer than the corresponding prior art compounds, especially the compound in which the sulfur atom of the benzothiophene ring of the above compound is replaced by an oxygen atom. Pharmaceutical compositions containing an effective amount of the compound of formula I, e.g. 1 to 5% by weight, in a pharmaceutical carrier are safer, more effective, and, in some cases, more reliable with fewer side effects than currently used antimycotic preparations.
Inventor(s): Foguet; Rafael (Barcelona, ES), Moreno; Marcial (Barcelona, ES), Raga; Manuel (Barcelona, ES), Cuberes; Rosa M. (Barcelona, ES), Castello; Jose M. (Barcelona, ES), Ortiz; Jose A. (Barcelona, ES)
Assignee: Ferrer Internacional S.A. (Barcelona, ES)
Application Number:07/649,764
Patent Claim Types:
see list of patent claims
Compound; Use; Composition;

No matches for this query

Foreign Priority and PCT Information for Patent: 5,135,943

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Spain529608Feb 02, 1984
Spain533353Jun 01, 1984
Spain535656Aug 06, 1984

International Patent Family for Patent: 5,135,943

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Canada1250586<disabled in preview>
Germany3579602<disabled in preview>
European Patent Office0151477<disabled in preview>
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc